Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug.
Their research, published today in the journal Molecular Pharmaceutics, shows how a new anti-heroin formulation that is safe in animal models remains stable at room temperature for at least 30 days. As a result, the vaccine is close to being ready for human testing.
“The heroin vaccine is one step closer to clinical evaluation,” says Candy S. Hwang, PhD, first author of the study and a research associate at TSRI.
According to the National Institute on Drug Abuse, 15,446 Americans died from heroin overdose between 2000 and 2016, and the mortality rates are increasing. Heroin abuse has been further fueled by a rise in prescription opioid abuse—studies show that opioid pain reliever users are 40 times more likely to abuse heroin.
The first formulation of the heroin vaccine was developed in 2013 by a team led by Kim D. Janda, PhD, the Ely R. Callaway Jr. Professor of Chemistry and member of the Skaggs Institute for Chemical Biology at TSRI. It has been shown to be effective—and safe—in both mouse and non-human primate models.
The vaccine works by training the immune system antibodies to recognize and bind to heroin molecules, blocking the drug from reaching the brain to cause a “high.” Researchers believe that blocking the high of heroin will help eliminate the motivation for many recovering addicts to relapse into drug use.
The heroin molecule does not naturally prompt an antibody response, so researchers attach it to a carrier protein that alerts the immune system to start making antibodies. Scientists also add an ingredient called an adjuvant to the vaccine, which boosts the immune response and makes the vaccine more effective.
Hwang says, “Our goal was to prepare a vaccine that could be advanced to clinical trials. As such, we were looking for the best combination of ‘hapten’ (the heroin molecule), carrier protein and adjuvant to keep the vaccine both stable for transport and storage but still efficacious.”
For the new study, the researchers investigated how 20 different carrier protein/adjuvant combinations worked, including shelf stability based on temperature and storage time and whether the formulation was a liquid or powder.
Their experiments in rodent models showed that the best vaccine formulation contained a carrier protein called tetanus toxoid (TT) and adjuvants called alum and CpG ODN. The discovery that alum worked best as an adjuvant was especially significant since alum is one of the few adjuvants used in vaccines already approved by the U.S. Food and Drug Administration. The researchers also found that there was no difference in how well it worked between the liquid and powder versions of this formulation.
Hwang notes that the best vaccine formulation showed protection against lethal doses of heroin. This is particularly important as many heroin addicts have succumb to overdose and death during their attempts to quit the drug.
With this new study, the researchers have shown that the vaccine is safe and effective in animal models, stable under clinical conditions and reliant on an already-approved adjuvant. The next step is to find a producer to make the vaccine on a large scale.
“We believe that a heroin vaccine would be tremendously beneficial for people who have a heroin substance use disorder but have found difficulty in trying to quit,” says Hwang.
Learn more: Heroin vaccine blocks lethal overdose
The Latest on: Heroin vaccine
via Google News
The Latest on: Heroin vaccine
- Lucky few hit COVID-19 vaccine jackpot for rare extra doseson January 22, 2021 at 8:54 pm
With millions of Americans waiting for their chance to get the coronavirus vaccine, a lucky few are getting bumped to the front of the line as clinics scramble to get rid of extra, perishable doses at ...
- Pfizer ships fewer Covid vaccine vials to U.S. after Trump FDA label changeon January 22, 2021 at 8:51 pm
Pfizer says the change to its label was made to “provide clarity to healthcare providers, minimize vaccine wastage and enable the most efficient use of the vaccine.” | Greg Lehman/Walla Walla ...
- More vaccines could be coming soon and they could be a big boost to the rollouton January 22, 2021 at 8:50 pm
States may be scrambling for vaccines now, but the United States could see additional Covid-19 vaccines by the end of March, if not sooner.Millions of ...
- Seattle ‘vaccine’ peddler arrested for selling untested drugon January 22, 2021 at 2:33 pm
SEATTLE (AP) — A suburban Seattle man who advertised a supposed COVID-19 “vaccine” he said he created in his personal lab, was arrested Thursday by federal authorities. Johnny T. Stine, ...
- Miss. senator shuns vaccine, encourages unapproved drug to treat COVID-19on January 22, 2021 at 11:16 am
JACKSON, Miss. (WLBT) - A former science teacher turned state senator has introduced a bill in the Mississippi legislature encouraging the use of an unapproved drug to treat COVID-19 in the state. The ...
- Paraguay inks deal with two drug companies for 3 million vaccine doses - health ministeron January 22, 2021 at 7:26 am
Paraguay signed agreements with two pharmaceutical companies to buy 3 million doses of coronavirus vaccines and plans to start vaccinations in the second half of February, Public Health Minister Julio ...
- Five Dead In India Vaccine Plant Fire; Covid Drug Unaffectedon January 21, 2021 at 8:45 am
Five people died as a fire tore through a building in the world's biggest vaccine manufacturing hub in India Thursday, but the company insisted the production of drugs to counter the coronavirus ...
- Major Fire At India Vaccine Plant But Coronavirus Drug Production Goes Onon January 21, 2021 at 4:22 am
Fire tore through part of the world's biggest vaccine production hub in western India on Thursday, but the company insisted that the production of drugs to counter the coronavirus pandemic was not ...
- Gritstone Oncology CEO on leveraging cancer drug development for coronavirus vaccineon January 20, 2021 at 7:53 pm
Gritstone Oncology CEO Andrew Allen explained how the nascent cancer drug developer caught the attention of the Gates Foundation in developing a potential coronavirus vaccine to slow the emergence of ...
- Hungarian drug regulator approves Sputnik V vaccine - websiteon January 20, 2021 at 2:13 pm
Hungary's national drug regulator has approved Russia's Sputnik V COVID vaccine, the Hungarian website Index.hu reported on Wednesday, citing unnamed sources.
via Bing News